|
1
|
Zur Hausen H: Papillomavirus infections -
a major cause of human cancers. Biochim Biophys Acta. 1288:55–78.
1996.
|
|
2
|
Kloth JN, Kenter GG, Spijker HS, et al:
Expression of Smad2 and Smad4 in cervical cancer: absent nuclear
Smad4 expression correlates with poor survival. Mod Pathol.
21:866–875. 2008.
|
|
3
|
Bookstein R and Allred DC: Recessive
oncogenes. Cancer. 71(Suppl 3): S1179–S1186. 1993.
|
|
4
|
Kamil JP, Hume AJ, Jurak I, Münger K,
Kalejta RF and Coena DM: Human papillomavirus 16 E7 inactivator of
retinoblastoma family proteins complements human cytomegalovirus
lacking UL97 protein kinase. Proc Natl Acad Sci USA.
106:16823–16828. 2009.
|
|
5
|
Heck DV, Yee CL, Howley PM and Münger K:
Efficiency of binding the retinoblastoma protein correlates with
the transforming capacity of the E7 oncoproteins of the human
papillomaviruses. Proc Natl Acad Sci USA. 89:4442–4446. 1992.
|
|
6
|
Matlashewski GJ, Tuck S, Pim D, Lamb P,
Schneider J and Crawford LV: Primary structure polymorphism at
amino acid residue 72 of human p53. Mol Cell Biol. 7:961–963.
1987.
|
|
7
|
Pim D and Banks L: p53 polymorphic
variants at codon 72 exert different effects on cell cycle
progression. Int J Cancer. 108:196–199. 2004.
|
|
8
|
Storey A, Thomas M, Kalita A, et al: Role
of a p53 polymorphism in the development of human
papillomavirus-associated cancer. Nature. 393:229–234. 1998.
|
|
9
|
Koushik A, Platt RW and Franco EL: p53
codon 72 polymorphism and cervical neoplasia: a meta-analysis
review. Cancer Epidemiol Biomarkers Prev. 13:11–22. 2004.
|
|
10
|
Jee SH, Won SY, Yun JE, Lee JE, Park JS
and Ji SS: Polymorphism p53 codon-72 and invasive cervical cancer:
a meta-analysis. Int J Gynaecol Obstet. 85:301–308. 2004.
|
|
11
|
Settheetham-Ishida W, Singto Y, Yuenyao P,
Tassaneeyakul W, Kanjanavirojkul N and Ishida T: Contribution of
epigenetic risk factors but not p53 codon 72 polymorphism to the
development of cervical cancer in Northeastern Thailand. Cancer
Lett. 210:205–211. 2004.
|
|
12
|
Lee SA, Kim JW, Roh JW, et al: Genetic
polymorphisms of GSTM1, p21, p53 and HPV infection with cervical
cancer in Korean women. Gynecol Oncol. 93:14–18. 2004.
|
|
13
|
Comar M, Molin GD, Guaschino S and
Campello C: p53 at codon 72 polymorphism, human papillomavirus
infection and cervical lesions: a cross-sectional study from
northeastern Italy. Eur J Obstet Gynecol Reprod Biol. 114:210–214.
2004.
|
|
14
|
Ueda M, Hung YC, Terai Y, Saito J,
Nunobiki O, Noda S and Ueki M: Glutathione-S-transferase and p53
polymorphisms in cervical carcinogenesis. Gynecol Oncol.
96:736–740. 2005.
|
|
15
|
Scambia G, Lovergine S and Masciullo V: RB
family members as predictive and prognostic factors in human
cancer. Oncogene. 25:5302–5308. 2006.
|
|
16
|
Soulitzis N, Sourvinos G, Sourvinos DN and
Spandidos DA: P53 codon 72 polymorphism and its association with
bladder cancer. Cancer Lett. 179:175–183. 2002.
|
|
17
|
Bereir RE, Mohamed HS, Seielstad M, et al:
Allele frequency and genotype distribution of polymorphisms within
disease-related genes is influenced by ethnic population
sub-structuring in Sudan. Genetica. 119:57–63. 2003.
|
|
18
|
Zur Hausen H: Papillomaviruses and cancer:
from basic studies to clinical application. Nat Rev Cancer.
2:342–350. 2002.
|
|
19
|
Smardová J, Nemajerová A, Trbusek M,
Vagunda V and Kovarík J: Rare somatic p53 mutation identified in
breast cancer: a case report. Tumor Biol. 22:59–66. 2001.
|
|
20
|
Zehbe I, Voglino G, Wilander E, et al: P53
codon 72 polymorphism and various human papillomavirus 16 E6
genotypes are risk factors for cervical cancer development. Cancer
Res. 61:608–611. 2001.
|
|
21
|
Kim JW, Lee CG, Han SM, et al: Loss of
heterozygosity of the retinoblastoma and p53 genes in primary
cervical carcinomas with human papillomavirus infection. Gynecol
Oncol. 67:215–221. 1997.
|
|
22
|
Park JS, Dong SM, Kim HS, et al: Detection
of p16 gene alteration in cervical cancer using tissue
microdissection and LOH study. Cancer Lett. 136:101–108. 1999.
|
|
23
|
Xing EP, Yang GY, Wang LD, Shi ST and Yang
CS: Loss of heterozygosity of the Rb gene correlates with pRb
protein expression and associates with p53 alteration in human
esophageal cancer. Clin Cancer Res. 5:1231–1240. 1999.
|
